3rd European Pharmacovigilance Congress

November 28-29, 2019 |  Milan (Italy)

#EUPV2019

Scientific Board

LUCIA COSTANZO

 Senior Conference Manager - PEC
Responsible  Person for the 

organization of the 

EUPV Congress 

FERNANDA FERRAZIN

 Former Head of Pharmacovigilance Dept.
- Italian Medicines Agency
 

Scientific Board - PEC
(Pharma Education Center)

    VALENTINA MANCINI  

EU QPPV
Shionogi 
 Europe

    PATRIZIA  ROTUNNO

Pharmacovigilance  Consulting, Drug  Safety  Manager of 

 Phast Consulting

MARCO SARDELLA
Chief Pharmacovigilance Officer 
EU QPPV ADIENNE Pharma &

Biotech, Chairperson for EU PV Congress 



speakers 2019

GLYN BELCHER, M.D. 

CEO of PV Consultancy Ltd

 

 

 

 

 

 

DAVID T CHONZI, M.D. 
  Vice President, Head of PV and Epidemiology, Allogene Therapeutics

 

SARAH HALL,
PhD

HonFPIPA,Managing Director MIPSOL

D'ANTUONO MARGHERITA, PharmD, PhD

Corporate  PV Director,  EU QPPV

Italfarmaco 

 

 

  PAOLA KRUGER

Expert Patient

EUPATI (European Patient's Academy for Therapeutic Innovation) 

LAURA BOGA

QPPV - Dompé Pharmaceutical Spa

 

 

 

 

 

 

 

FABIO DE  GREGORIO
Vice President, Head of Drug Safety Europe,
Shionogi Europe
  

 

HERVE' LE LOUET, M.D., PhD
President of CIOMS, member of PRAC

GIAN NICOLA CASTIGLIONE,
M.D.

EU QPPV & Director Global  PV - Chiesi Farmaceutici 

 

 

 

 

PHILLIP EICHORN, M.D.

 Senior Director Worldwide Safety & Regulatory - Pfizer Pharmaceuticals 

  

CALIN A. LUNGU, M.D. 

MRQA, BCPM, Eudravigilance and XEVMPD-EMA, CEO-DDCS

FILIPPO

CERRUTI

Senior Director Legal at Gilead Sciences

 

 

 

 

 

 

GIOVANNI FURLAN,

Pharm.D.
 Safety Risk Lead, Director

Pfizer 

 

 

ARDUINO MANGONI,

MBBS, MD (Hons), PhD
Professor and Head, Department of Clinical Pharmacology,

School of Medicine, Flinders University, Australia

MIRCEA CIUCA, M.D. 

Global Therapeutic Area Head (Immunology & Neurology/Transplant), in Global Clinical Safety and Pharmacovigilance at CSL Behring

ILARIA GRISONI
Sr. Director,
EEA QPPV
Jazz Pharmaceutical
 

 

 

DANIELA MARCOZZI 

Head of QA
GCP & GVP
Fidia Farmaceutici


NELE MATTHIJS 

PV Inspector-DG Inspection - FAMHP - Federal Agency for Medicines and Health Products, Brussels Area, Belgium 

GIOVANNI

NAVALESI,

M.D.

Scientific director at PHARM D&S 

JOSE' ALBERTO

AJALA ORTIZ

PVpharm CEO, EU QPPV, 

PV Consultant,

LCPPV Services

Spain 

PAOLA

PIROVANO

Head of Drug Safety & QPPV Recordati 

 KEYA PITTS,

MPH

Executive Head, Quality, Standars and Compliance, Global Patient Safety and Risk Management at Alnylam Pharmaceuticals - USA

PAOLO PORCELLI

GVP Senior Inspector, GCP and GMP API Inspector in training,

Inspection and Certification Department- AIFA (Italian Medicines Agency)


 FRANCOISE DUMAS SILLAN, M.D. 

Vice President, Head Global QPPV office at Pfizer 

DORIS IRENE STENVER,
D.M.,MPA
Indep. PV Adviser Founder of Unique Advice, former Chief Medical Officer Danish Medicines Agency and former member of PRAC

GUERRINA BARBARA

TESTONI
Chief Operations Officer in Dueali consulting srl  

 ALESSANDRA TRAVERSA

Independent Pharmacovigilance Expert 

BERT VAN LEEUWEN, M.D.

Deputy-QPPV of Astellas Pharma

ANNA RUTH VAN TROOSTENBURG DE  BRUYN  

 tGP MD(Lond) FFPM,EU QPPV & VP, Pharmacovigilance & Epidemiology,

Gilead Sciences